Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation

Mingxing Zheng1, Zhibing Zhu2, Yongzhao Zhao3

  • 1Department of Respiratory Medicine, Clinical College of Anhui Medical University Affiliated Shenzhen Second People's Hospital, Shenzhen, Guangdong 518035, P.R. China.

Molecular Medicine Reports
|December 14, 2016
PubMed

Insights

Oridonin halts lung cancer cell growth by triggering cell cycle arrest. This occurs via the ATM-p53-CHK2 pathway, offering a potential cancer treatment mechanism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Oridonin, derived from Rabdosia rubescens, is known to inhibit tumor cell proliferation and induce apoptosis.
  • The precise mechanisms by which oridonin influences cell cycle progression are not fully elucidated.

Purpose of the Study:

  • To investigate the mechanisms underlying oridonin-induced cell cycle arrest in A549 lung cancer cells.
  • To explore the role of the ATM-p53-CHK2 pathway in oridonin's anti-cancer effects.

Main Methods:

  • Cell cycle analysis using flow cytometry.
  • Western blot analysis to detect key protein phosphorylation levels (ATM, CHK2, p53, H2AX).

Main Results:

  • Oridonin induced a dose-dependent G2/M cell cycle arrest in A549 lung cancer cells.
  • Treatment with oridonin increased the phosphorylation of ATM, CHK2, p53, and H2AX.
  • These findings suggest the involvement of the ATM-p53-CHK2 signaling pathway.

Conclusions:

  • Oridonin promotes G2/M cell cycle arrest in A549 lung cancer cells.
  • The mechanism involves the activation of the ATM-p53-CHK2 pathway.
  • This pathway activation may be a common mechanism for oridonin's anti-cancer activity in various tumor types.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
6.2K